{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:51:36Z","timestamp":1764075096597,"version":"3.45.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-04139-7","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:45:21Z","timestamp":1764074721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["POLE-mutated atypical endometrial hyperplasia in an adolescent: a 5-year follow-up with LNG-IUS\u2014a case report and literature review"],"prefix":"10.1186","volume":"25","author":[{"given":"Jun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"4139_CR1","doi-asserted-by":"crossref","unstructured":"Emad Rakha SC, Wong, BMedSc. AM J SURG PATHOL. 2012;36(11):1683\u201390.","DOI":"10.1097\/PAS.0b013e31825dd4ff"},{"issue":"22","key":"4139_CR2","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.3390\/diagnostics14222471","volume":"14","author":"AJ Chou","year":"2024","unstructured":"Chou AJ, Bing RS, Ding DC. Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer. Diagnostics (Basel). 2024;14(22):2471.","journal-title":"Diagnostics (Basel)"},{"key":"4139_CR3","doi-asserted-by":"publisher","unstructured":"Clarke MA, Long BJ, Sherman ME. et. (2020). A prospective clinical cohort study of women at increased risk for endometrial cancer. Gynecol Oncol. 2020;156(1):169\u2013177. https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.014","DOI":"10.1016\/j.ygyno.2019.09.014"},{"key":"4139_CR4","doi-asserted-by":"publisher","unstructured":"Monica WR, Julia T, Emily KK, Yolanda RS, Carolyn J, Elisabeth HQ. (2019). Risk factors for endometrial cancer or hyperplasia in adolescents and women 25 years old or younger. North American Society for Pediatric and Adolescent Gynecology. 32, 5, 546\u20139. https:\/\/doi.org\/10.1016\/j.jpag.2019.06.004","DOI":"10.1016\/j.jpag.2019.06.004"},{"key":"4139_CR5","unstructured":"Royal College of Obstetricians and Gynaecologists (RCOG). Management of Endometrial Hyperplasia [Internet]. Green-top Guideline No. 89. London: RCOG; 2022 Jun [cited 2023 Oct 15]."},{"key":"4139_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039619","volume":"2024","author":"Y Yao","year":"2024","unstructured":"Yao Y, Xu S, Wang T, Jiang R. Efficacy of drugs treatment in patients with endometrial hyperplasia with or without atypia: a systematic review and network meta-analysis. Medicine (Baltimore). 2024;2024:e39619. https:\/\/doi.org\/10.1097\/MD.0000000000039619.","journal-title":"Medicine (Baltimore)"},{"key":"4139_CR7","doi-asserted-by":"publisher","unstructured":"Tepper Naomi K, Whiteman Maura K, March banks Polly A, James Andra H, Curtis Kathryn M. Progestin-only contra ception and thromboembolism: a systematic review, Contraception (2016). https:\/\/doi.org\/10.1016\/j.contraception.2016.04.014","DOI":"10.1016\/j.contraception.2016.04.014"},{"key":"4139_CR8","doi-asserted-by":"publisher","unstructured":"Tao M, Wu T, Zhou X et al. (2024). Comparative effects of different treatments based on the levonorgestrel intrauterine system in endometrial carcinoma and endometrial hyperplasia patients: a network meta-analysis. Arch Gynecol Obstet 310, 1315\u20131329 (2024). https:\/\/doi.org\/10.1007\/s00404-024-07608-w","DOI":"10.1007\/s00404-024-07608-w"},{"key":"4139_CR9","doi-asserted-by":"publisher","unstructured":"Goh CSY, Loh MJM, Lim WW et al. (2024). A multi-centre randomised controlled trial comparing megestrol acetate to levonorgestrel-intrauterine system in fertility sparing treatment of atypical endometrial hyperplasia. J Assist Reprod Genet. 2024;41(9):2485\u20132494. https:\/\/doi.org\/10.1007\/s10815-024-03172-z","DOI":"10.1007\/s10815-024-03172-z"},{"issue":"1","key":"4139_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12958-022-01006-0","volume":"20","author":"Y Ding","year":"2022","unstructured":"Ding Y, Fan Y, Li X, et al. Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients. Reprod Biol Endocrinol. 2022;20(1):134. https:\/\/doi.org\/10.1186\/s12958-022-01006-0.","journal-title":"Reprod Biol Endocrinol"},{"key":"4139_CR11","doi-asserted-by":"publisher","unstructured":"Ogunbiyi MO, Oxley S, Graham R, Olaitan A. The oncological and reproductive outcomes of fertility-preserving treatments for stage 1 grade 1 endometrial carcinoma: a systematic review and meta-analysis. J Obstet Gynaecol. 2023;44(1). https:\/\/doi.org\/10.1080\/01443615.2023.2294329.","DOI":"10.1080\/01443615.2023.2294329"},{"key":"4139_CR12","unstructured":"Green Top Guideline No. 67-Management of Endometrial Hyperplasia: RCOG\/BSGE Joint Guideline February 2016.67:0\u201330."},{"issue":"1","key":"4139_CR13","doi-asserted-by":"publisher","first-page":"hoac057","DOI":"10.1093\/hropen\/hoac057","volume":"2023","author":"A Rodolakis","year":"2023","unstructured":"Rodolakis A, Scambia G, Planchamp F, et al. ESGO\/ESHRE\/ESGE guidelines for the fertility-sparing treatment of patients with endometrial carcinoma[J]. Hum Reprod Open. 2023;2023(1):hoac057. https:\/\/doi.org\/10.1093\/hropen\/hoac057.","journal-title":"Hum Reprod Open"},{"issue":"11","key":"4139_CR14","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1093\/humrep\/det320","volume":"28","author":"ID Gallos","year":"2013","unstructured":"Gallos ID, Krishan P, Shehmar M, et al. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study. HUM REPROD. 2013;28(11):2966\u201371. https:\/\/doi.org\/10.1093\/humrep\/det320. -11-01.","journal-title":"HUM REPROD"},{"key":"4139_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejogrb.2024.01.033","volume":"295","author":"S Jang","year":"2024","unstructured":"Jang S, Sung OH. The risk factors for premalignant and malignant endometrial polyps in premenopausal and postmenopausal women and trends over the past decade: A retrospective study in a single center, South Korea. Eur J Obstet Gynecol Reproductive Biology Volume. 2024;295:118\u201312. https:\/\/doi.org\/10.1016\/j.ejogrb.2024.01.033.","journal-title":"Eur J Obstet Gynecol Reproductive Biology Volume"},{"key":"4139_CR16","doi-asserted-by":"publisher","unstructured":"Ribeiro-Santos P, Martins Vieira C, Viana Veloso GG et al. (2024). Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment. Int J Mol Sci. 2024;25(14):7742. https:\/\/doi.org\/10.3390\/ijms25147742","DOI":"10.3390\/ijms25147742"},{"issue":"1","key":"4139_CR17","doi-asserted-by":"publisher","first-page":"100016","DOI":"10.1016\/j.ijgc.2024.100016","volume":"35","author":"FA Ferrari","year":"2025","unstructured":"Ferrari FA, et al. Performance of molecular classification in predicting oncologic outcomes of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer. INT J GYNECOL CANCER. 2025;35(1):100016. https:\/\/doi.org\/10.1016\/j.ijgc.2024.100016. 2025-01-01.","journal-title":"INT J GYNECOL CANCER"},{"key":"4139_CR18","doi-asserted-by":"publisher","unstructured":"Liu Q, Zhou H, Yu M et al. (2025). GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol. Trials. 2024;25(1):578. https:\/\/doi.org\/10.1186\/s13063-024-08414-0","DOI":"10.1186\/s13063-024-08414-0"},{"issue":"4","key":"4139_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ajog.2015.03.037","volume":"213","author":"AH Hatem","year":"2015","unstructured":"Hatem AH, Essam G, Mohamed ER, et al. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials. Am J Obstet Gynecol. 2015;213(4):469\u201378. https:\/\/doi.org\/10.1016\/j.ajog.2015.03.037.","journal-title":"Am J Obstet Gynecol"},{"key":"4139_CR20","doi-asserted-by":"publisher","first-page":"1391546","DOI":"10.3389\/fonc.2024.1391546","volume":"14","author":"J Cui","year":"2024","unstructured":"Cui J, Zhao Y-C, She L-Z, Wang T-J. Comparative effects of progestin-based combination therapy for endometrial cancer or atypical endometrial hyperplasia: a systematic review and network meta-analysis. Front Oncol. 2024;14:1391546. https:\/\/doi.org\/10.3389\/fonc.2024.1391546.","journal-title":"Front Oncol"},{"key":"4139_CR21","doi-asserted-by":"publisher","unstructured":"Lv X, Guo L, Wang C. (2024). Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia. Journal of Gynecologic Oncology. 2024;35(3): e27. https:\/\/doi.org\/10.3802\/jgo.2024.35.e27","DOI":"10.3802\/jgo.2024.35.e27"},{"key":"4139_CR22","doi-asserted-by":"publisher","unstructured":"Leino A. Nostolahti, Anton, Ahtikoski, Anne, et. Molecular subtype and mutational profile of endometrial atypical Hyperplasia\/Endometrioid intraepithelial neoplasia. Int J Gynecol Pathology:April. 2025;29. https:\/\/doi.org\/10.1097\/PGP.0000000000001113.","DOI":"10.1097\/PGP.0000000000001113"},{"issue":"9","key":"4139_CR23","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1136\/ijgc-2024-005711","volume":"34","author":"E Chacon","year":"2024","unstructured":"Chacon E, Boria F, Lyer RR, et al. SENECA study: staging endometrial cancer based on molecular classification. Int J Gynecol Cancer. 2024;34(9):1313\u201321. https:\/\/doi.org\/10.1136\/ijgc-2024-005711.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"4139_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/PGP.0000000000001008","volume":"43","author":"N Liu","year":"2024","unstructured":"Liu N, Lin W, Wang Y, With PTEN, et al. Predicting Progestin Therapy Response With PTEN, PAX2, and \u03b2-Catenin in Patients With Endometrioid Precancer. International Journal of Gynecological Pathology. 2024;43(5):494\u2013505. https:\/\/doi.org\/10.1097\/PGP.0000000000001008.","journal-title":"International Journal of Gynecological Pathology"},{"key":"4139_CR25","doi-asserted-by":"publisher","unstructured":"Hartwich T, Mansolf M, Demirkiran C et al. (2024). Preclinical evaluation of avutometinib and defactinib in high-grade endometrioid endometrial cancer. Cancer Medicine. 2024;13: e70210. https:\/\/doi.org\/10.1002\/cam4.70210","DOI":"10.1002\/cam4.70210"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04139-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-04139-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04139-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:45:24Z","timestamp":1764074724000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-04139-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4139"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-04139-7","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Clerk Association of Zhongshan City People\u2019s Hospital. (Approval No.:2025-032)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian for both the publication of this case report and the use of anonymized clinical data, including imaging and histopathological findings.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"573"}}